AHRQ solicits comments on pediatric EHR core functions

Laura Pedulli | | Health Exec | EMR/EHR

The Agency for Healthcare Research and Quality is requesting feedback on a draft technical brief on core functions of pediatric EHRs.

The document aims to help healthcare decisionmakers, such as patients, providers, health system leaders and policymakers, make well-informed decisions and ultimately improve healthcare quality, according to the 67-page brief.

The brief found that there is expert consensus in the literature that EHRs for pediatric care require specific functionalities. These functions relate to a child’s evolving physiology and maturity and involve the following areas: vaccination; development; physiologic medication dosing; pediatric disease management; pediatric norms; and the relationship between pediatric patients and their caregivers.

According to experts, “if these functionalities are implemented well, the EHR will also better support the care of all patients,” according to the report.

The agency is accepting comments through 11:59 p.m. Eastern time. Read the report. 

Laura Pedulli

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.